Transcranial Magnetic Stimulation System Market To Reach $594.49 Million By 2033

Transcranial Magnetic Stimulation System Market Growth & Trends

The global transcranial magnetic stimulation system market is anticipated to reach USD 594.49 million by 2033 and is projected to register a CAGR of 9.89% from 2025 to 2033, according to a new report by Grand View Research, Inc. according to a new report by Grand View Research, Inc. The transcranial magnetic stimulation system market is expected to grow owing to the increasing prevalence of neurological diseases such as Parkinson's Disease, Alzheimer's Disease, and other neurological problems, along with the increasing technological advancements.

According to FDA in October 2020, due to the COVID-19 public health emergency, there has been a short term negative impact on the market. The decrease was primarily driven by a lower number of transcranial magnetic stimulation systems sold in the quarter. For instance, Neuronetics, Inc. sold 38 systems, down from 43 systems in the first quarter of 2019 as a result of the impact of COVID-19. However, as of March 2020, the active unit installed base in the U.S. was 1,119. This represents an increase of 188 units, or 20%, over the active unit installed base as of March 31, 2019, and an increase of 34 units over the active installed base as of December 31, 2019.            

Companies are constantly launching new products in the existing market to expand their product portfolio and increase the revenue of the company. For instance, in July 2022, according to Neuronetics, the FDA approved their NeuroStar Advanced Therapy for Mental Health transcranial magnetic stimulation device for treating anxiety symptoms in people with major depressive disorder. Additionally, the FDA approved the transcranial magnetic stimulation (TMS) system as an additional form of treatment for people with OCD. The non-drug, non-invasive therapy is the first TMS system for depression to receive FDA approval. The transcranial magnetic stimulation system market is predicted to increase at a high rate as a result of these advancements.

 Request a free sample copy or view report summary: Transcranial Magnetic Stimulation System Market Report

Transcranial Magnetic Stimulation System Market Report Highlights

• The repetitive transcranial magnetic stimulation segment held the largest revenue share of 67.34% in 2024 as repetitive transcranial magnetic stimulation (rTMS) is the most widely adopted form of TMS therapy, in which repeated magnetic pulses are applied to specific regions of the brain across multiple treatment sessions.

• The depression segment held the largest revenue share in 2024 owing to rising global prevalence of depression, the increasing burden of TRD, and the growing preference for non-pharmacological, non-invasive therapies with fewer side effects compared to antidepressants.

• The adults segment held the largest share in 2024 as adults are more likely to be diagnosed with major depressive disorder and other mental health conditions that are effectively treated with TMS, leading to higher demand within this demographic.

• North America transcranial magnetic stimulation system industry accounted for the largest revenue share of 57.59% in 2024, driven primarily by the rising prevalence of neurological and psychiatric disorders, including depression, anxiety, Parkinson’s disease, and Alzheimer’s disease.

Transcranial Magnetic Stimulation System Market Segmentation

Grand View Research has segmented the global transcranial magnetic stimulation system market on the basis of type, application, age group, and region:

Transcranial Magnetic Stimulation System Type Outlook (Revenue, USD Million, 2021 - 2033)

• Deep Transcranial Magnetic Stimulation

• Repetitive Transcranial Magnetic Stimulation

• Others

Transcranial Magnetic Stimulation System Application Outlook (Revenue, USD Million, 2021 - 2033)

• Alzheimer’s Disease

• Depression

• Parkinson’s Disease

• Epilepsy

• Others

Transcranial Magnetic Stimulation System Age Group Outlook (Revenue, USD Million, 2021 - 2033)

• Adults

• Children

Transcranial Magnetic Stimulation System Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • Kuwait

  • UAE

List of Key Players in the Transcranial Magnetic Stimulation System Market

• Nexstim

• BrainsWay

• Magstim (Welcony)

• MagVenture A/S

• eNeura, Inc.

• NeuroStar (Neuronetics)

• Neurosoft

• CloudNeuro

• Soterix Medical Inc.

• Brain Ultimate Inc.

• DEYMED Diagnostic s.r.o.

• Salience TMS (Salience Health)

• NeuroQore (Ontario Brain Institute)

• SEBERS Medical

• neurocare group AG (MAG & More)

• Shenzhen Yingchi Technology Co., Ltd.

• Shanghai Goodmed Medical Device Co., Limited

• Guangzhou MeCan Medical Limited

• Others